Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Eye Disease (TED)”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Large-scale testing (Phase 3)Study completedNCT06384547
What this trial is testing

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 231
Large-scale testing (Phase 3)Looking for participantsNCT07262476
What this trial is testing

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease (TED)
Minghui Pharmaceutical (Hangzhou) Ltd 258
Large-scale testing (Phase 3)UnknownNCT05015127
What this trial is testing

Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Who this might be right for
Thyroid Ophthalmopathy
Harbour BioMed (Guangzhou) Co. Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT05683496
What this trial is testing

Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
ACELYRIN Inc. 31
Early research (Phase 1)Looking for participantsNCT07597200
What this trial is testing

A Clinical Study of Cizutamig in Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TED
Candid Therapeutics 38
Large-scale testing (Phase 3)Not Yet RecruitingNCT07620405
What this trial is testing

Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease (TED)
Minghui Pharmaceutical (Hangzhou) Ltd 219
Large-scale testing (Phase 3)Looking for participantsNCT07257185
What this trial is testing

MHB018A Treatment in Patients With Chronic Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease (TED)
Minghui Pharmaceutical (Hangzhou) Ltd 150
Large-scale testing (Phase 3)Study completedNCT06126783
What this trial is testing

A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TED
Innovent Biologics (Suzhou) Co. Ltd. 91
Large-scale testing (Phase 3)Study completedNCT05176639
What this trial is testing

A Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants With Thyroid Eye Disease (TED) ( THRIVE )

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 113
Testing effectiveness (Phase 2)Study completedNCT01868997
What this trial is testing

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

Who this might be right for
Thyroid Associated OphthalmopathiesThyroid-Associated Ophthalmopathy
Amgen 88
Large-scale testing (Phase 3)Ended earlyNCT04737330
What this trial is testing

The Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves Orbitopathy
Novartis Pharmaceuticals 28
Post-approval studies (Phase 4)Not Yet RecruitingNCT07308964
What this trial is testing

Comparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Disease

Who this might be right for
Thyroid Eye DiseaseThyroid Eye Disease, TEDThyroid Eye Disease (TED)
Sheba Medical Center 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06106828
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Hoffmann-La Roche 127
Large-scale testing (Phase 3)Study completedNCT05517421
What this trial is testing

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Immunovant Sciences GmbH 114
Large-scale testing (Phase 3)Study completedNCT05524571
What this trial is testing

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Immunovant Sciences GmbH 86
Large-scale testing (Phase 3)Looking for participantsNCT07211776
What this trial is testing

Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease (TED)
Zai Lab (Shanghai) Co., Ltd. 99
Large-scale testing (Phase 3)Not Yet RecruitingNCT07622108
What this trial is testing

Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study

Who this might be right for
Thyroid Eye Disease, TED
Minghui Pharmaceutical (Hangzhou) Ltd 84
Large-scale testing (Phase 3)Active Not RecruitingNCT06625398
What this trial is testing

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 204
Post-approval studies (Phase 4)Looking for participantsNCT07152340
What this trial is testing

The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.

Who this might be right for
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital 64
Not applicableStudy completedNCT07444190
What this trial is testing

Psychological Burden of Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TED
Thomas Jefferson University 20
Load More Results